Skip to main content
. 2023 Apr 20;14:1164788. doi: 10.3389/fendo.2023.1164788

Figure 2.

Figure 2

Prevalence of metabolic disease and each component of metabolic disease according to NAD+ levels. Metabolic disease is defined as hypertension, hyperlipidemia, diabetes, hyperuricemia, obesity, or NAFLD among the whole participants. NAFLD, non-alcoholic fatty liver disease; *indicates p < 0.05; **p < 0.01; ***p < 0.001; Comparison between 2nd, 3rd, 4th vs 1st quartile of the NAD+ levels.